ID

33084

Descrição

Study ID: 104020 Clinical Study ID: 104020 Study Title: Blinded, randomised study to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ live attenuated measles-mumps-rubella-varicella candidate vaccine when given to healthy children in their second year of life Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00126997 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Combined Measles, Mumps, Rubella, Varicella Vaccine Trade Name: Priorix Tetra Study Indication: Measles; Mumps; Rubella; Varicella

Palavras-chave

  1. 26/11/2018 26/11/2018 -
Titular dos direitos

GSK group of companies

Transferido a

26 de novembro de 2018

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Immunogenicity of Combined Measles, Mumps, Rubella, Varicella Vaccine for healthy 2 y.o children - 104020

Study Conclusion Form

  1. StudyEvent: ODM
    1. Study Conclusion Form
Administrative data
Descrição

Administrative data

Subject Number
Descrição

Subject Number

Tipo de dados

integer

Occurrence of Serious Adverse Event
Descrição

Occurrence of Serious Adverse Event

Did the subject experience any Serious Adverse Events during the study period?
Descrição

Did the subject experience any Serious Adverse Events during the study period?

Tipo de dados

boolean

If Yes, please specify total number of SAE's
Descrição

If Yes, please specify total number of SAE's

Tipo de dados

integer

Status of treatment blind
Descrição

Status of treatment blind

Was the treatment blind broken during this study?
Descrição

For the control group, please tick 'No'

Tipo de dados

boolean

If Yes, please complete date
Descrição

If Yes, please complete date

Tipo de dados

date

Check the reason of blind breach
Descrição

Check the reason of blind breach

Tipo de dados

integer

If Other, specify
Descrição

complete Non-Serious Adverse Event section or Serious Adverse Event form as appropriate

Tipo de dados

text

Elimination Criteria
Descrição

Elimination Criteria

Did any elimination criteria become applicable during the study?
Descrição

Did any elimination criteria become applicable during the study?

Tipo de dados

boolean

If Yes, specify
Descrição

If Yes, specify

Tipo de dados

text

Was the subject withdrawn from study?
Descrição

Was the subject withdrawn from study?

Tipo de dados

boolean

If Yes, please tick the ONE most appropriate category for withdrawal
Descrição

If Yes, please tick the ONE most appropriate category for withdrawal

Tipo de dados

text

If SAE, please specify SAE Number
Descrição

If SAE, please specify SAE Number

Tipo de dados

integer

If Non-SAE please specify unsolicited AE Number
Descrição

If Non-SAE please specify unsolicited AE Number

Tipo de dados

integer

If Protocol violation, please specify
Descrição

If Protocol violation, please specify

Tipo de dados

text

If Other, please specify
Descrição

If Other, please specify

Tipo de dados

text

Please tick who took decision
Descrição

Please tick who took decision

Tipo de dados

text

Date of last contact
Descrição

Date of last contact

Tipo de dados

date

Was the subject in good condition at date of last contact?
Descrição

Was the subject in good condition at date of last contact?

Tipo de dados

text

Investigator's Signature
Descrição

Investigator's Signature

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my collegues is, to the best of my knowledge, complete and accurate, as of the date below.
Descrição

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my collegues is, to the best of my knowledge, complete and accurate, as of the date below.

Tipo de dados

date

Investigator's signature
Descrição

Investigator's signature

Tipo de dados

text

Printed Investigator's name
Descrição

Printed Investigator's name

Tipo de dados

text

Similar models

Study Conclusion Form

  1. StudyEvent: ODM
    1. Study Conclusion Form
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Administrative data
Subject Number
Item
Subject Number
integer
Item Group
Occurrence of Serious Adverse Event
Did the subject experience any Serious Adverse Events during the study period?
Item
Did the subject experience any Serious Adverse Events during the study period?
boolean
If Yes, please specify total number of SAE's
Item
If Yes, please specify total number of SAE's
integer
Item Group
Status of treatment blind
Was the treatment blind broken during this study?
Item
Was the treatment blind broken during this study?
boolean
If Yes, please complete date
Item
If Yes, please complete date
date
Item
Check the reason of blind breach
integer
Code List
Check the reason of blind breach
CL Item
Medical emergency requiring identification of investigational product for further treatments (1)
CL Item
Other (2)
If Other, specify
Item
If Other, specify
text
Item Group
Elimination Criteria
Did any elimination criteria become applicable during the study?
Item
Did any elimination criteria become applicable during the study?
boolean
If Yes, specify
Item
If Yes, specify
text
Was the subject withdrawn from study?
Item
Was the subject withdrawn from study?
boolean
Item
If Yes, please tick the ONE most appropriate category for withdrawal
text
Code List
If Yes, please tick the ONE most appropriate category for withdrawal
CL Item
Serious adverse event (check SAE number) (1)
CL Item
Non-Serious adverse events (check the Non-SAE) (2)
CL Item
Protocol violation (3)
CL Item
Consent withdrawal, not due to an adverse event (4)
CL Item
Migrated/moved from the study area (5)
CL Item
Lost to follow-up (6)
CL Item
Other (7)
If SAE, please specify SAE Number
Item
If SAE, please specify SAE Number
integer
If Non-SAE please specify unsolicited AE Number
Item
If Non-SAE please specify unsolicited AE Number
integer
If Protocol violation, please specify
Item
If Protocol violation, please specify
text
If Other, please specify
Item
If Other, please specify
text
Item
Please tick who took decision
text
Code List
Please tick who took decision
CL Item
Investigator (1)
CL Item
Parents/Guardians (2)
Date of last contact
Item
Date of last contact
date
Item
Was the subject in good condition at date of last contact?
text
Code List
Was the subject in good condition at date of last contact?
CL Item
Yes (1)
CL Item
No, please give details within the Adverse Events section (2)
Item Group
Investigator's Signature
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my collegues is, to the best of my knowledge, complete and accurate, as of the date below.
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my collegues is, to the best of my knowledge, complete and accurate, as of the date below.
date
Investigator's signature
Item
Investigator's signature
text
Printed Investigator's name
Item
Printed Investigator's name
text

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial